Sight Sciences (SGHT) FCF Margin (2020 - 2026)
Sight Sciences' (SGHT) quarterly FCF Margin came in at 35.99% in Q1 2026, up 3030.0% year-on-year from 1.15% in Q1 2025, and down 359.38% quarter-over-quarter from 7.83% in Q4 2025.
Sight Sciences (SGHT) FCF Margin (2020 - 2026) Analysis & Trends
Sight Sciences' FCF Margin history runs 7 years deep, the most recent figure standing at 35.99% for Q1 2026.
- On a quarterly basis, FCF Margin rose 3030.0% year-over-year to 35.99% in Q1 2026; TTM through Mar 2026 was 31.84%, a 81.0% decrease from a year earlier, with the FY2025 full-year figure at 38.58%, down 1053.0% from the prior year.
- FCF Margin declined to 35.99% in Q1 2026 per SGHT's latest filing, from 7.83% in the prior quarter.
- Across five years, FCF Margin topped out at 1.54% in Q3 2024 and bottomed at 147.54% in Q1 2022.
- The 5-year median for FCF Margin is 50.22% (2023), against an average of 57.62%.
- Across the five-year window, FCF Margin surged 6221 bps in 2023 and slumped 4620 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 71.42% in 2022, then jumped by 51 bps to 34.72% in 2023, then jumped by 51 bps to 17.1% in 2024, then jumped by 54 bps to 7.83% in 2025, then plunged by 359 bps to 35.99% in 2026.
- Per Business Quant, the three latest SGHT FCF Margin figures stand at 35.99% (Q1 2026), 7.83% (Q4 2025), and 44.65% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | -35.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.99% |
| Dec 31, 2025 | -7.83% |
| Sep 30, 2025 | -44.65% |
| Jun 30, 2025 | -39.63% |
| Mar 31, 2025 | -66.28% |
| Dec 31, 2024 | -17.10% |
| Sep 30, 2024 | 1.54% |
| Jun 30, 2024 | -45.28% |
| Mar 31, 2024 | -50.73% |
| Dec 31, 2023 | -34.72% |
| Sep 30, 2023 | -50.22% |
| Jun 30, 2023 | -58.37% |
| Mar 31, 2023 | -92.41% |
| Dec 31, 2022 | -71.42% |
| Sep 30, 2022 | -112.43% |
| Jun 30, 2022 | -106.50% |
| Mar 31, 2022 | -147.54% |
| Dec 31, 2021 | -74.08% |
| Sep 30, 2021 | -128.23% |
| Jun 30, 2021 | -93.98% |